Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated Chinese and Western medicine interventions for pain relief in lower extremity arteriosclerosis obliterans
ChiCTR1800016710Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of flurbiprofen in arteriosclerosis obliterans (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Frequency of rest pain attacks, Duration of rest pain and 2 more. Started Jul 2018; status: recruiting.
02
Drugs
flurbiprofen
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on ChiCTR1800016710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016710.